| 3/5/2024 | 300215000000 | IMMUNITY PRODUCT (LABELLED CARTON CONTAINING 1X VIAL OF AVELUMAB (BAVENCIO) 20ML/ML CONCENTRATE FOR +SOLUTION FOR INFUSION 200MG/10ML VIAL) (TO BE USED IN CLINICAL RESEARCH) | 200 | SET | 234302 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/11/2024 | 300215000000 | IMMUNITY PRODUCT (LABELLED 1X CARTON CONTAINING AB122 (ZIMBERELIMAB) 30MG/ML INJECTION SOLUTION FOR +INTRAVENUS USE 120MG/4ML VIAL) (TO BE USED IN CLINICAL RESEARCH) | 250 | SET | 17571 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/5/2024 | 300215000000 | IMMUNITY PRODUCT (LABELLED CARTON CONTAINING MEDI5752 POWDER FOR SOLUTION FOR INFUSION 250 )(TO BE USED IN CLINICAL + RESEARCH) | 65 | SET | 29051 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/5/2024 | 300215000000 | IMMUNITY PRODUCT (LABELLED CARTON CONTAINING 16 VIALS OF SACITUZUMAB GOVITECAN (IMMU 132) LYOPHILIZE+D 200 MG/50ML) (TO BE USED IN CLINICAL RESEARCH) | 50 | SET | 237208 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/11/2024 | 300215000000 | IMMUNITY PRODUCT (LABELLED 1X CARTON CONTAINING 5ML/300MG DOMVANALIMAB CONCENTRATE FOR SOLUTION FOR +INFUSION 60MG/ML VIAL) (TO BE USED IN CLINICAL RESEARCH) | 250 | SET | 43849 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/20/2024 | 300215000000 | IMMUNITY PRODUCT (LABELED 1X CARTON CONTAINING SACITUZUMAB GOVITECAN LYOPHILIZED POWDER FOR SOLUTION+ FOR INFUSION 200 MG VIAL) (TO BE USED IN CLINICAL RESEARCH) | 225 | SET | 67619 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |